Pfizer Ltd. (PFIZER) Share Price Hits Fresh 52-Week Low at Rs 4,303
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
Pfizer Ltd. Share Price is Rs 4,313.45, down 6.11% today after hitting a fresh 52-week low of Rs 4,303. Market capitalisation stands at Rs 21,017.65 crore.
Pfizer Ltd. Share Price fell to Rs 4,313.45 on 09 September 2026, down Rs 280.80 or 6.11% from the previous close of Rs 4,594.25, after the stock touched a fresh 52-week low of Rs 4,303. The company’s market capitalisation stood at Rs 21,017.65 crore at the time of the event. For investors tracking Pfizer Ltd. Share Price Today, the verified data confirms a sharp one-day decline and a new yearly low, but it does not establish a company-specific catalyst behind the move.
That is why Pfizer Ltd. Stock News is drawing attention in today’s Stock Market Today and Share Market Today screens. The price event is significant because it places the stock among Stocks at 52 Week Low and Top Losers Today, while the supplied financial metrics still show profitability, positive return ratios and a valuation profile that sits below the same-industry median P/E. Univest notes that the next factors to monitor are whether the stock stabilises after this 52-week trough, how its valuation compares with peers, and whether recent earnings momentum remains intact.
Pfizer Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,313.45 |
| Previous Close | Rs 4,594.25 |
| Today's Move | Rs -280.8 (-6.11%) |
| Open | Rs 4,599.95 |
| High | Rs 4,599.95 |
| Low | Rs 4,303 |
| Turnover | Rs 2.72 crore |
| Market Capitalisation | Rs 21,017.65 crore |
Pfizer Ltd. (PFIZER) traded at Rs 4,313.45 versus the previous close of Rs 4,594.25, a fall of 6.11%. The stock opened at Rs 4,599.95, reached a high of Rs 4,599.95, touched a low of Rs 4,303.
Pfizer Ltd. Share Price Today showed clear intraday weakness, with the stock opening at Rs 4,599.95, which was also the day’s high, before falling to a day low of Rs 4,303 and then trading at Rs 4,313.45. Against the previous close of Rs 4,594.25, that translates into a loss of Rs 280.80 or 6.11%. Turnover stood at Rs 2.72 crore, while market capitalisation was Rs 21,017.65 crore during the move.
The structure of the session matters. Pfizer Ltd. Share Price opened above the previous close by Rs 5.70, but selling pressure intensified quickly enough to drag it from the opening high to the fresh one-year low. That kind of Price Action often keeps a stock in the Stocks in News and Market Movers list even when the supplied data does not identify a company-specific reason. For readers searching Pfizer Ltd. Share Price Live or Pfizer Ltd. Share Price Update, the main fact is straightforward: the stock reset its 52-week low at Rs 4,303 and remained close to that level in early trade, keeping Bearish Stocks and 52 Week Low Stocks screens focused on the counter.
Pfizer Ltd. (PFIZER) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 21,017.65 crore |
| P/E Ratio | 26.84x |
| P/B Ratio | 4.48x |
| ROE | 17.16% |
| ROCE | 23.39% |
| EPS | Rs 160.7 |
| Book Value Per Share | Rs 963.41 |
| Dividend Yield | 1.74% |
Pfizer Ltd. (PFIZER) fundamental metrics show P/E 26.84x, P/B 4.48x, ROE 17.16%, ROCE 23.39%. These figures provide context only and are not a buy or sell signal.
Pfizer Ltd. has a market capitalisation of Rs 21017.65 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.84x, P/B at 4.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.74%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.68x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.84x |
| Benchmark Median P/E | 32.68x |
| Benchmark Average P/E | 49.27x |
| Benchmark P/E Range | 3.39x to 668.68x |
| Company P/B Ratio | 4.48x |
| Benchmark Median P/B | 3x |
| Company ROE | 17.16% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 23.39% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 21,017.65 crore |
| Benchmark Median Market Cap | Rs 704.3 crore |
Pfizer Ltd. (PFIZER) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Pfizer Ltd. (PFIZER) has a P/E ratio of 26.84x, which is below the benchmark median of 32.68x, a difference of -17.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.81%, a difference of +45.3%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.68%, a difference of +70.98%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 21,386.27 | 31.71 | 5.74 | 20.79 | 24.97 |
| Granules India Ltd. | GRANULES | 21,475.32 | 33.53 | 4.53 | 14.13 | 15.74 |
| Eris Lifesciences Ltd. | ERIS | 18,346.35 | 28.52 | 4.55 | 19.23 | 14.47 |
| Shilpa Medicare Ltd. | SHILPAMED | 18,337.75 | 63.11 | 6.99 | 9.82 | 11.43 |
| Suven Pharmaceuticals Ltd. | COHANCE | 17,193.92 | 162.59 | 4.49 | 4.02 | 6.12 |
Pfizer Ltd. (PFIZER) has a P/E ratio of 26.84x compared with the displayed peer median of 33.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.16% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 21,017.65 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Pfizer Ltd.
- Pfizer Ltd. Share Price fell 6.11% in a single session and hit a fresh 52-week low of Rs 4,303.
- The stock moved from an opening and intraday high of Rs 4,599.95 to near the day low, highlighting sharp selling pressure.
- Fundamental ratios remain notable, with P/E at 26.84, ROE at 17.16, ROCE at 23.39, EPS at 160.7 and dividend yield at 1.74.
- Same-industry data shows the company trading below the median P/E but above the median ROE and ROCE.
- Peer comparison places Pfizer close to several mid-to-large pharmaceutical names on market cap, but with a distinct valuation profile.
About Pfizer Ltd.
Pfizer Ltd. (PFIZER) operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied company classification, the stock is part of India’s listed pharmaceutical universe, where investors typically evaluate companies on profitability, valuation, earnings consistency, return ratios and market positioning relative to other healthcare names.
For readers following Pfizer Ltd. Company News, the current focus is less on a disclosed operating trigger in the supplied data and more on how the listed business is being priced by the market. The company’s presence in a 200-company same-industry benchmark and a 287-company same-sector universe means Pfizer Ltd. Share Price is being assessed alongside a broad set of pharmaceutical and healthcare peers. That is why current Pfizer Ltd. Latest News interest is centred on its fresh 52 Week Low, earnings metrics, return ratios and relative valuation inside the healthcare pack.
Track Pfizer Ltd. Share Price on Univest
Use Pfizer Ltd. (PFIZER) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
On Univest, users can track Pfizer Ltd. Share Price, Pfizer Ltd. Share Price Today, 52-week levels, market insights, key fundamental ratios, quarterly financial trends and peer positioning in one place. Univest also helps investors follow stock analysis across the Indian Stock Market, including price action, sector context and company metrics that shape Pfizer Ltd. Stock News and broader Market News screens.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Pfizer Ltd. Share Price in focus today?
Ans. Pfizer Ltd. Share Price is in focus because it fell 6.11% to Rs 4,313.45 after touching a fresh 52-week low of Rs 4,303. The supplied data confirms the price event and market capitalisation of Rs 21,017.65 crore.
What was the fresh 52-week low for Pfizer Ltd.?
Ans. The fresh 52-week low for Pfizer Ltd. was Rs 4,303. The stock later traded at Rs 4,313.45, compared with a previous close of Rs 4,594.25, keeping the counter near its yearly low during the session.
Why is Pfizer Ltd. falling today?
Ans. The supplied data confirms that Pfizer Ltd. fell sharply today, but it does not establish a company-specific catalyst for the decline. What is verified is the 6.11% drop, the fresh one-year low and turnover of Rs 2.72 crore.
What does today’s price action show for Pfizer Ltd.?
Ans. Today’s price action shows a weak session. Pfizer Ltd. opened at Rs 4,599.95, which was also the day’s high, then fell to Rs 4,303 before trading at Rs 4,313.45, indicating sustained intraday selling pressure.
How is Pfizer Ltd. valued right now?
Ans. Pfizer Ltd. is valued at a P/E of 26.84 and a P/B of 4.48. Its earnings multiple is below the same-industry median P/E of 32.68, while its price-to-book is above the median P/B of 3.00.
Are Pfizer Ltd.’s profitability ratios still strong?
Ans. Pfizer Ltd. shows ROE of 17.16 and ROCE of 23.39 in the supplied data. Both ratios are above the same-industry medians of 11.81 and 13.68, indicating stronger profitability than the benchmark middle.
What are the key earnings and balance sheet metrics for Pfizer Ltd.?
Ans. The supplied metrics show EPS of 160.7, book value per share of Rs 963.41 and dividend yield of 1.74. Balance-sheet assets were Rs 41,748.40 crore in 2024, while debt-to-assets is shown at 0 through 2026.
How does Pfizer Ltd. compare with peers?
Ans. Pfizer Ltd.’s P/E of 26.84 is lower than Caplin Point, Granules India, Eris Lifesciences, Shilpa Medicare and Suven Pharmaceuticals. Its ROCE of 23.39 is above four of those five peers and only slightly below Caplin Point.
What do the latest quarterly numbers show for Pfizer Ltd.?
Ans. Recent financials show revenue rising from Rs 6,030.50 crore in Jun 2025 to Rs 6,531.70 crore in Jun 2026. Net profit moved from Rs 1,917.50 crore to Rs 2,044.70 crore across the same comparison points.
What should investors monitor next in Pfizer Ltd. Stock News?
Ans. Investors may monitor whether Pfizer Ltd. Share Price stabilises after the fresh 52-week low, how valuation compares with peers and industry benchmarks, and whether quarterly revenue, profit, ROE and ROCE remain consistent in upcoming updates.
